These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11679451)

  • 1. Acute fructose administration improves oral glucose tolerance in adults with type 2 diabetes.
    Moore MC; Davis SN; Mann SL; Cherrington AD
    Diabetes Care; 2001 Nov; 24(11):1882-7. PubMed ID: 11679451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute fructose administration decreases the glycemic response to an oral glucose tolerance test in normal adults.
    Moore MC; Cherrington AD; Mann SL; Davis SN
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4515-9. PubMed ID: 11134101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ingestion of an exogenous ketone monoester improves the glycemic response during oral glucose tolerance test in individuals with impaired glucose tolerance: A cross-over randomized trial.
    Nakagata T; Tamura Y; Kaga H; Sato M; Yamasaki N; Someya Y; Kadowaki S; Sugimoto D; Satoh H; Kawamori R; Watada H
    J Diabetes Investig; 2021 May; 12(5):756-762. PubMed ID: 33010116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactate generation following glucose ingestion: relation to obesity, carbohydrate tolerance and insulin sensitivity.
    Lovejoy J; Mellen B; Digirolamo M
    Int J Obes; 1990 Oct; 14(10):843-55. PubMed ID: 2269580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-tagatose, a novel hexose: acute effects on carbohydrate tolerance in subjects with and without type 2 diabetes.
    Donner TW; Wilber JF; Ostrowski D
    Diabetes Obes Metab; 1999 Sep; 1(5):285-91. PubMed ID: 11225640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of insulin secretion by fructose ingested with protein in people with untreated type 2 diabetes.
    Gannon MC; Nuttall FQ; Grant CT; Ercan-Fang S; Ercan-Fang N
    Diabetes Care; 1998 Jan; 21(1):16-22. PubMed ID: 9538964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Double-Blind, Randomized Controlled, Acute Feeding Equivalence Trial of Small, Catalytic Doses of Fructose and Allulose on Postprandial Blood Glucose Metabolism in Healthy Participants: The Fructose and Allulose Catalytic Effects (FACE) Trial.
    Braunstein CR; Noronha JC; Glenn AJ; Viguiliouk E; Noseworthy R; Khan TA; Au-Yeung F; Blanco Mejia S; Wolever TMS; Josse RG; Kendall CWC; Sievenpiper JL
    Nutrients; 2018 Jun; 10(6):. PubMed ID: 29890724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic treatment with acarbose on glucose and lipid metabolism in obese diabetic Wistar rats.
    Carrascosa JM; Molero JC; Fermín Y; Martínez C; Andrés A; Satrústegui J
    Diabetes Obes Metab; 2001 Aug; 3(4):240-8. PubMed ID: 11520303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute metabolic response to high-carbohydrate, high-starch meals compared with moderate-carbohydrate, low-starch meals in subjects with type 2 diabetes.
    Gannon MC; Nuttall FQ; Westphal SA; Fang S; Ercan-Fang N
    Diabetes Care; 1998 Oct; 21(10):1619-26. PubMed ID: 9773720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Influence of Pre-Exercise Glucose versus Fructose Ingestion on Subsequent Postprandial Lipemia.
    Yang TJ; Chiu CH; Tseng MH; Chang CK; Wu CL
    Nutrients; 2018 Jan; 10(2):. PubMed ID: 29382142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in hypopituitary adults.
    al-Shoumer KA; Beshyah SA; Niththyananthan R; Johnston DG
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):85-90. PubMed ID: 7889636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese men.
    Matikainen N; Söderlund S; Björnson E; Bogl LH; Pietiläinen KH; Hakkarainen A; Lundbom N; Eliasson B; Räsänen SM; Rivellese A; Patti L; Prinster A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
    Nutr Metab Cardiovasc Dis; 2017 Jun; 27(6):534-542. PubMed ID: 28428027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of breakfast meal composition on second meal metabolic responses in adults with Type 2 diabetes mellitus.
    Clark CA; Gardiner J; McBurney MI; Anderson S; Weatherspoon LJ; Henry DN; Hord NG
    Eur J Clin Nutr; 2006 Sep; 60(9):1122-9. PubMed ID: 16670695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of breakfast fat content on glucose tolerance and risk factors of atherosclerosis and thrombosis.
    Frape DL; Williams NR; Rajput-Williams J; Maitland BW; Scriven AJ; Palmer CR; Fletcher RJ
    Br J Nutr; 1998 Oct; 80(4):323-31. PubMed ID: 9924274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects.
    Del Rio G; Procopio M; Bondi M; Marrama P; Menozzi R; Oleandri SE; Grottoli S; Maccario M; Velardo A; Ghigo E
    Int J Obes Relat Metab Disord; 1997 Dec; 21(12):1111-4. PubMed ID: 9426377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes.
    Hawkins M; Gabriely I; Wozniak R; Vilcu C; Shamoon H; Rossetti L
    Diabetes; 2002 Mar; 51(3):606-14. PubMed ID: 11872657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of added fat on plasma glucose and insulin response to ingested potato in individuals with NIDDM.
    Gannon MC; Ercan N; Westphal SA; Nuttall FQ
    Diabetes Care; 1993 Jun; 16(6):874-80. PubMed ID: 8325201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes.
    Herman GA; Bergman A; Stevens C; Kotey P; Yi B; Zhao P; Dietrich B; Golor G; Schrodter A; Keymeulen B; Lasseter KC; Kipnes MS; Snyder K; Hilliard D; Tanen M; Cilissen C; De Smet M; de Lepeleire I; Van Dyck K; Wang AQ; Zeng W; Davies MJ; Tanaka W; Holst JJ; Deacon CF; Gottesdiener KM; Wagner JA
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4612-9. PubMed ID: 16912128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired circulating glucagon-like peptide-1 response to oral glucose in women with previous gestational diabetes.
    Forbes S; Moonan M; Robinson S; Anyaoku V; Patterson M; Murphy KG; Ghatei MA; Bloom SR; Johnston DG
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):51-5. PubMed ID: 15638870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.